COLLABORATE El Meu Clínic . This link opens in a new tab.
Search
COLLABORATE El Meu Clínic . This link opens in a new tab.
Navigation thread
Virginia Hernández-Gea

Virginia Hernández-Gea

Médico Hepatólogo, HCB

Research group

//orcid.org/0000-0001-7937-984X 0000-0001-7937-984X

Featured publications

  • Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs.

    Authors:
    Llaneras J; Riveiro-Barciela M; Lens S; Diago M; Cachero A;
    (...)
    Iñarrairaegui M; Pascasio JM; Esteban R; Mariño Z; Buti M .
    Reference: Journal Of Hepatology 2019.

  • Porto-sinusoidal vascular disease: proposal and description of a novel entity

    Authors:
    de Gottardi, Andrea; Rautou, Pierre-Emmanuel; Schouten, Jeoffrey; Rubbia-Brandt, Laura; Leebeek, Frank;
    (...)
    Willa, Dominique; Garcia-Pagan, Juan Carlos; Jakob, Brigitte; Cazals-Hatem, Dominique; Alonso, Cristina.
    Reference: Lancet Gastroenterology & Hepatology 2019.

  • Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis

    Authors:
    Reverter, Enric; Lozano, Juan J; Alonso, Cristina; Berzigotti, Annalisa; Seijo, Susana;
    (...)
    Martinez-Arranz, Ibon; La Mura, Vincenzo; Hernandez-Gea, Virginia; Bosch, Jaume; Garcia-Pagan, Juan C.
    Reference: Liver International 2019.

  • TIPS Indications and Contraindications—Pushing the Limits: Is Earlier Better?

    Authors:
    José Ferrusquía‐Acosta; Virginia Hernández‐Gea;
    Reference: Current Hepatology Reports 2019.

  • Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis.

    Authors:
    Enric Reverter; Juan José Lozano; Cristina Alonso; Annalisa Berzigotti; Susana Seijo;
    (...)
    Ibon Martínez Arranz; Vincenzo La Mura; Virginia Hernández Gea; Jaume Bosch; Juan Carlos García Pagán.
    Reference: Liver International 2019.

  • Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

    Authors:
    Herreros-Villanueva M; Duran-Sanchon S; Martín AC; Pérez-Palacios R; Vila-Navarro E;
    (...)
    García-Cougil M; Martínez-Arranz I; Castells A; Gironella M; Arroyo R .
    Reference: Clinical And Translational Gastroenterology 2019.

  • Idiopathic Portal Hypertension

    Authors:
    Hernandez Gea, Virginia; Baiges, Anna; Turon, Fanny; García-Pagán JC;
    Reference: Hepathology 2018.

  • Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury.

    Authors:
    Maria Ruart; Laia Chavarria; Genís Campreciós; Nuria Suárez Herrera; Carla Montironi;
    Sergi Guixé Muntet; Jaume Bosch; Scott L Friedman; Juan Carlos Garcia Pagán; Virginia Hernández Gea.
    Reference: Journal Of Hepatology 2018.

  • Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis

    Authors:
    Payancé A; Silva-Junior G; Bissonnette J; Tanguy M; Pasquet B;
    (...)
    Valla D; Durand F; Boulanger CM; Garcia-Pagan JC3; Rautou PE.
    Reference: 2018.

  • Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.

    Authors:
    Simón-Talero M; Roccarina D; Martinez J; Lampichler K; Baiges A;
    (...)
    Reiberger T; Albillos A; sochatzis EA; Augustin S; Genescà J.
    Reference: 2018.

Featured Projects

  • La autofagia endotelial gobierna la respuesta de la célula hepática estrellada al daño hepático: regeneración o fibrosis? Análisis del secretoma endotelial para el desarrollo de nuevos tratamientos antibibroticos

    Principal investigator: Virginia Hernandez Gea
    Funder: Instituto de Salud Carlos III
    Code: PI17/00398
    Duration: 01/01/2018 - 31/12/2020

  • Papel de la autofagia en la modulación de la disfunción endotelial y la fibrosis: caracterización de una nueva diana terapéutica para el desarrollo de nuevos tratamientos antifibróticos

    Principal investigator: Virginia Hernández Gea
    Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Instituto de Salud Carlos III
    Code: FIS PI14/00182
    Duration: 01/01/2014 - 31/12/2017

  • HEPTROMIC: Genomic predictors and oncogenic drivers in hepatocellular carcinoma

    Principal investigator: Jessica Zucman Rossi
    Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); European Commission (FP7-2010-Health.2.4.1-6 )
    Duration: 03/09/2012 - 31/05/2013

  • Autophagy During hepatic stellate cell activation in alcoholic liver injury

    Principal investigator: Scott L. Friedman
    Funder: Mount Sinai School of Medicine (Sede o evento); NIAAA/RFA-AA-11-002
    Duration: 01/01/2011 - 30/09/2012

  • Role of Stellate Cells in Hepatic Fibrosis

    Principal investigator: Scott L. Friedman
    Funder: Mount Sinai School of Medicine (Sede o evento); NIH, NIDDK
    Duration: 01/01/2011 - 30/09/2012